We’re joining the fight against cancer. We're proud to sponsor the Curebound Cancer Challenge and support research bringing us closer to a cure. Run, walk, or ride with Team Johnson & Johnson. https://t.co/f7aXFWesg5
Cancer has touched so many lives—including our own teams, families, and communities—and we’re honored to support the mission of the Curebound Cancer Challenge. Join us as we run, walk, and ride to make an impact. https://t.co/f7aXFWesg5
Controlling chronic autoimmune disease is one thing - moving beyond control and into "deep healing" is another. Sign up to watch our latest webinar now to learn more: https://t.co/7n5RLZEFA5
Lung cancer remains one of the most pressing global health challenges, & we are committed to changing that. Join us for a scientific symposium where attendees can hear from our oncology leaders & engage in an interactive Q&A. Register today: https://t.co/KE2Hp6t02c
"Deep tissue healing" following chronic autoimmune disease is about more than anti-inflammatory approaches. In our latest webinar, we explore innovations in this field, and potential ways to bring these innovations to patients. Watch now: https://t.co/7n5RLZEFA5
Our leaders are back from BIO and are excited to share their insights from their time onsite with team members. The future of biotech is bright & we’re excited to be a part of it!
Proud to be a sponsor of the Curebound Cancer Challenge with Johnson & Johnson! Join us in the fight against cancer. Sign up today 6/26 to take advantage of the early bird special. Let’s make a difference together. https://t.co/f7aXFWesg5
Join Johnson & Johnson on July 6 in Seattle, Washington for an exclusive scientific symposium spotlighting lung cancer innovation. Register for the program today! https://t.co/KE2Hp6t02c
As BIO day 3 comes to a close, we’re grateful for the opportunity to be onsite and engage with leaders who share our mission in advancing healthcare for people around the world. Looking forward to the final day tomorrow.
If you’re an innovator focused on targeting solid tumors, we want to hear from you!
Apply by July 1, for the chance to present to J&J leadership. https://t.co/J84gp2XxY4
What an amazing Fireside Chat! John Reed and Nauman Shah sat down to speak more on the transformational therapies developed at Johnson & Johnson, how we partner, and the future of innovative medicine.
Today at BIO, Lesley Stolz joined a panel with leaders from Merck and Morgan Stanley to discuss what big pharma companies are really looking for when it comes to differentiated science.
Coming up at BIO today: a Fireside Chat Super Session featuring John Reed and Nauman Shah, who will be highlighting innovation at Johnson & Johnson, our mission to source globally, and our strategies for getting science to patients.
Innovators don’t need a full company, a polished pitch deck, or a large investor syndicate to take the next scientific step. They need the right collaborators and a realistic plan for key experiments." Learn more about PPPs in our latest blog: https://t.co/YS5HldSOuA
A PPP (public-private-partnership) can help startups get access to resources and networks to take their innovation to the next level. In his latest blog, Viggo Van Tendeloo, Director, Search and Evaluation, explores the considerations: https://t.co/YS5HldSOuA
BIO is just around the corner. Our team will be onsite looking to connect with other attendees, so be sure to seek them out to learn more about our biotech initiatives. We look forward to meeting you onsite!